Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Ulitryp 1,00,000IU Injection
Manufacturer/Marketed By : BHARAT SERUMS & VACCINES LTD
$20.40 $13.92
Ulitryp 1,00,000IU Injection contains an active component as Ulinastatin. It is also known as a urinary trypsin inhibitor (UTI). It is a medication used in some countries for its anti-inflammatory...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
ULINASTATIN
Active Pharmaceutical Ingredient
Ulitryp 1,00,000IU Injection
$20.40
$13.92
Ulitryp 1,00,000IU Injection contains an active component as Ulinastatin. It is also known as a urinary trypsin inhibitor (UTI). It is a medication used in some countries for its anti-inflammatory and immunomodulatory effects. It was initially isolated from human urine and has been studied for potential therapeutic benefits. The primary use is the treatment of acute pancreatitis, a condition characterized by pancreas inflammation. It is believed to work by inhibiting certain enzymes and factors involved in the inflammatory response, thus helping to reduce the severity of the condition. Additionally, Ulitryp 1,00,000IU Injection has been investigated for its potential benefits in other conditions, including sepsis (severe bacterial infection), multiple organ failure, and acute respiratory distress syndrome (ARDS). Its ability to modulate the immune response and reduce inflammation makes it a candidate for these conditions where excessive immune reactions can damage tissue. Ulitryp 1,00,000IU Injection may not be suitable for everyone. It is contraindicated in patients with a known hypersensitivity to the drug or its components. Limited research may be available regarding the safety and efficacy of this medication in certain populations, such as pediatric patients or the elderly. Extra caution and expert guidance are needed when using this medication in these groups. Ulitryp 1,00,000IU Injection may interfere with certain laboratory tests, potentially affecting the accuracy of results. Inform your healthcare provider about using this medication if you undergo diagnostic tests. Abruptly stopping treatment, especially in critically ill patients, may have adverse effects.
Active Pharmaceutical Ingredient
Uses
• Acute pancreatitis
• Sepsis
• Acute respiratory distress syndrome
Benefits
Ulitryp 1,00,000IU Injection's mechanism of action involves inhibiting various proteolytic enzymes, such as trypsin and elastase, which are crucial in promoting inflammation and tissue damage. By suppressing these enzymes, this medication reduces the activation of inflammatory pathways and modulates the immune response, ultimately leading to decreased inflammation and potential mitigation of tissue injury.
Side Effects
Ulitryp 1,00,000IU Injection causes some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Nausea
• Vomiting
• Diarrhea
• Skin rashes or itching
• Headache
• Dizziness
• Fever or chills
• Injection site reactions (pain, redness, or swelling)
Common Side Effects
• Severe allergic reactions (difficulty breathing, swelling of the face or throat, hives, itching)
• Anaphylaxis (a life-threatening allergic reaction)
• Signs of an infection (fever, persistent sore throat)
• Changes in kidney function (changes in urine output, swelling of the legs or ankles)
• Abnormal bleeding or bruising
• Liver problems (yellowing of the skin or eyes, dark urine, abdominal pain)
• Neurological symptoms (confusion, seizures, difficulty speaking or moving)
How To Use
Ulitryp 1,00,000IU Injection is administered intravenously (vein injection) under medical supervision. Your healthcare professional will determine the specific dosage and administration guidelines based on your condition and needs.
Safety Advice
• Breast Feeding: If you are breastfeeding or planning to breastfeed and require treatment with Ulitryp 1,00,000IU Injection, it is crucial to discuss the matter thoroughly with your healthcare provider.
• Alcohol: Both alcohol and Ulitryp 1,00,000IU Injection can impact the central nervous system, and combining the two may cause increased drowsiness or impair cognitive function.
• Liver: If you have a liver condition or concerns about Ulitryp 1,00,000IU Injection's safety in your liver health, it is crucial to discuss this with your healthcare provider.
• Lungs: If you have a lung condition or are considering Ulitryp 1,00,000IU Injection treatment for any respiratory issue, it is vital to consult with a qualified healthcare professional. They can assess your medical history, perform a thorough evaluation, and determine the most appropriate treatment plan.
• Driving: Ulitryp 1,00,000IU Injection can cause certain side effects that may impair your ability to drive safely. These side effects can include dizziness, lightheadedness, blurred vision, and transient changes in heart rhythm. These effects can interfere with your concentration, alertness, and coordination, making driving potentially unsafe.
• Pregnancy: If you are pregnant or planning to become pregnant and require treatment with Ulitryp 1,00,000IU Injection, it is crucial to consult your healthcare provider.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.